The stability factor: importance in formulation development.
about
Glycosylation of therapeutic proteins: an effective strategy to optimize efficacyCoarse-grained strategy for modeling protein stability in concentrated solutions. II: phase behavior.Growth factor delivery-based tissue engineering: general approaches and a review of recent developmentsBioactivity of WLBU2 peptide antibiotic in combination with bioerodible polymer.Nanofibrous scaffolds for dental and craniofacial applications.Coarse-grained strategy for modeling protein stability in concentrated solutions. III: directional protein interactionsDevelopment of dextran nanoparticles for stabilizing delicate proteinsEffects of glycosylation on the stability of protein pharmaceuticals.Aggregates in monoclonal antibody manufacturing processes.Analytical methods and formulation factors to enhance protein stability in solution.Nanogels: An overview of properties, biomedical applications and obstacles to clinical translationIn situ formation of poly(vinyl alcohol)-heparin hydrogels for mild encapsulation and prolonged release of basic fibroblast growth factor and vascular endothelial growth factor.Coarse-grained strategy for modeling protein stability in concentrated solutions.Development of Stabilized Growth Factor-Loaded Hyaluronate- Collagen Dressing (HCD) matrix for impaired wound healing.Investigation of purification process stresses on erythropoietin peptide mapping profile.Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?ε-Polylysine-based thermo-responsive adsorbents for immunoglobulin adsorption-desorption under mild conditions.
P2860
Q33586660-77C190ED-DC6B-4EEF-84D0-AD9B24C7C3CAQ34418777-A5C4C3D6-F320-4977-857E-AB6BD6293B0EQ34548765-6241F265-6BB9-494D-91F1-E4CD22711805Q35501031-4F0A9A61-5725-4241-AD8D-6C8CDD1C72DDQ35744416-7DD74DEC-B937-4B50-9442-6C1E3F776FE2Q35812331-2ED7A22E-C663-45B2-8557-996E6171F267Q36849488-191CD7F0-0308-4B83-A890-836E4292280FQ37114305-B34BC43B-7F9C-4E68-99B9-813151BEA181Q37863609-B8F08581-BAF8-4DC8-8269-118FE70E1386Q38065104-CB022D37-DB44-42D4-A665-064F1504622DQ38634048-C8A3A6E4-EDFC-4FAA-BBD6-C3CB5D8D379DQ38728480-573F97FC-C20B-44C3-8713-65151B939F09Q41825816-97E935FE-FEB8-4DB7-A87C-5B2B729E889CQ41862846-A0454E9B-9A23-4474-BF67-0C0F5C5C6180Q42010530-0F8A9AEB-C008-49DF-A612-58618F1D9C42Q42855410-9774BBAC-F84B-47B1-B3AA-D12E77C970DDQ53208789-4DFEAD3F-E843-4826-ABF2-6E3AA0C31631
P2860
The stability factor: importance in formulation development.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The stability factor: importance in formulation development.
@ast
The stability factor: importance in formulation development.
@en
type
label
The stability factor: importance in formulation development.
@ast
The stability factor: importance in formulation development.
@en
prefLabel
The stability factor: importance in formulation development.
@ast
The stability factor: importance in formulation development.
@en
P356
P1476
The stability factor: importance in formulation development.
@en
P2093
Mark C Manning
Rajesh Krishnamurthy
P304
P356
10.2174/1389201023378229
P577
2002-12-01T00:00:00Z